Yhn ScienceBiology first seen 2 d ago, last 48 min ago, peak #4
Novo Nordisk and Eli Lilly report GLP-1 signs of slowed biological aging
Original: Novo Nordisk, Eli Lilly Report GLP-1 Signals of Slowed Biological Aging at ARDD
Novo Nordisk and Eli Lilly presented findings at the Aging Research and Drug Discovery (ARDD) meeting suggesting their GLP-1 drugs may slow biological aging, beyond their established effects on diabetes and weight loss. The reports fuel ongoing debate about whether drugs like Ozempic and Mounjaro could double as longevity treatments, and what the evidence actually shows.
Why now: GLP-1 drugs are already hugely popular, and hints they might slow aging dramatically expand their potential use.
Novo NordiskEli LillyARDDGLP-1 drugsOzempic
Rank over time, top of the chart is #1. 8 snapshots from 5 h ago to 48 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2933411